IZOZ.F Stock Overview
Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Izotropic Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.10 |
52 Week High | CA$0.36 |
52 Week Low | CA$0.054 |
Beta | 2.11 |
1 Month Change | 0% |
3 Month Change | 17.65% |
1 Year Change | -67.20% |
3 Year Change | -89.36% |
5 Year Change | -60.00% |
Change since IPO | -63.64% |
Recent News & Updates
Recent updates
Shareholder Returns
IZOZ.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 11.1% | -0.2% | 1.3% |
1Y | -67.2% | 10.6% | 29.8% |
Return vs Industry: IZOZ.F underperformed the US Medical Equipment industry which returned 10.6% over the past year.
Return vs Market: IZOZ.F underperformed the US Market which returned 29.8% over the past year.
Price Volatility
IZOZ.F volatility | |
---|---|
IZOZ.F Average Weekly Movement | 33.9% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IZOZ.F's share price has been volatile over the past 3 months.
Volatility Over Time: IZOZ.F's weekly volatility has increased from 27% to 34% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | Bob Thast | https://izocorp.com |
Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation Fundamentals Summary
IZOZ.F fundamental statistics | |
---|---|
Market cap | US$5.46m |
Earnings (TTM) | -US$3.33m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.5x
P/E RatioIs IZOZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IZOZ.F income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$4.51m |
Earnings | -CA$4.51m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.082 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -56.5% |
How did IZOZ.F perform over the long term?
See historical performance and comparison